Agreed patience is required but still need to be vigilant. Pig headed stubborness can be rewarded will big capital loss.
Suggest holders have a look at Pharmaxis (PXS). Aussie Biotech just missed primary endpoint on phase 3 trial.
One of the posters thanked what he calls the "blackhats" or pesimists on HC for helping him avoid a substantial capital loss.
Of course, PXS is no MSB, PXS it had all its eggs in one basket and this egg turned out to be rotten (apparently?)but think the posters point is worth consideration.
msb, page-10
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |